Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics.
Read more about cookies
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era
sep. 2025
Fernando, Carceller, et al
European Journal of Cancer
Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6)
aug. 2025
, et al
The Lancet Oncology
Correlative studies in central nervous system tumors clinical trials
aug. 2025
Raoull, Hoogendijk, et al
Neuro-Oncology
Author Correction
jul. 2025
Lindsay B., Kilburn, et al
Nature medicine
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?
